Vitro Diagnostics Inc. (PINK: VODG), owner of U.S. patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes, has seen a huge jump in its shares in trading today.
VODG shares rose to an intra-day high of $0.27 today before shedding some of the gains. At last check, the stock was trading 228.60% higher at $0.185 on above average volume of 978,260.
So what’s pushing VODG shares higher today?
It looks like the surge could be due to some stock promotion activity as Vitro Diagnostics has released any major news in the last one month.
Last month, Vitro Diagnostics, doing business as Vitro Biopharma, had announced that it received approval for its presentation entitled “GMP Cell Culture Media for Expansion of MSCS Prior to Allogeneic or Autologous Transplantation.” VODG said that it will present its current findings at the annual meeting of the International Society of Cellular Therapy (ISCT) in Seattle, Washington in June.
Dr. Jim Musick, President and CEO of Vitro Diagnostic, said that VODG is pleased to be approved for presentation at the ISCT annual meeting. Musick said that it is apparent from the reported widespread efficacy of MSCs in clinical trials and the low incidence of adverse effects that there is potential to achieve regulatory approval for advanced treatment of many diseases, injuries and cellular degenerative conditions.